The combined therapy with bivalos and alfacalcidolium in correction of mineral density of a bone fabric and prevention osteoporosis crises


Cite item

Full Text

Abstract

In article questions of pharmacological correction of postmenopausal osteoporosis with bivalos and alfacalcidolum are considered. Monitoring of clinical semiology, indicators of a mineral exchange and a bone metabolism, densitometric parameters has allowed to draw a conclusion on high effi ciency of the offered method, capable to raise synthetic function a bone fabric. Optimisation exchange calcium-phosphoric, balance restoration bones’ remodelation in aggregate with a gain of mineral density defi nes prevention possibilities osteoporotic crises.

About the authors

Воронежская государственная медицинская академия им. Н.Н.Бурденко

Author for correspondence.
Email: Rostislavina_i@mail.ru
соискатель кафедры транспортной медицины ИПМО Воронежской государственной медицинской академии им. Н.Н.Бурденко, ревматолог городской клинической поликлиники №4;

Дорожная клиническая больница на ст. Воронеж–1 ОАО «РЖД»

Email: Rostislavina_i@mail.ru
д.м.н., ассистент кафедры транспортной медицины ИПМО Воронежской государственной медицинской академии им. Н.Н.Бурденко, заведующая ревматологическим отделением Дорожной клинической больницы на станции Воронеж-1 ОАО "РЖД";

Воронежская государственная медицинская академия им. Н.Н.Бурденко

Email: dmmad@yandex.ru
к.м.н., ассистент кафедры клинической фармакологии Воронежской государственной медицинской академии им. Н.Н.Бурденко;

References

  1. Benevolenskaia L.I., Nikitinskaia O.A. Osteoporoz na rubezhe XXI veka. Kachestvo zhizni. Meditsina 2006; 5: 10-13.
  2. Ershova O.B. Kal'tsii i vitamin D v profilaktike i lechenii osteoporoza s tochki zreniia dokazatel'noi meditsiny. Problemi osteologiï 2006; 9; 43.
  3. Lazebnik L.B. i dr. Epidemiologiia, profilaktika, varianty klinicheskogo techeniia, lechenie osteoporoza i ego oslozhnenii: metodicheskoe. M. 2004; 48.
  4. Lesniak O.M., Benevolenskoi L.I. Rossiiskaia assotsiatsiia po osteoporozu. Osteoporoz. Diagnostika, profilaktika i lechenie: klinicheskie rekomendatsii. M. GEOTAR-Media 2009; 27.
  5. Mikhailov E.E., Men'shikova L.V., Ershova O.B. Epidemiologiia osteoporoza i perelomov v Rossii. Prilozhenie k zhurnalu "Osteoporoz i osteopatii": materialy Rossiiskogo kongressa po osteoporozu. Moskva. 20-22 okt. 2003. M. 2003; 44.
  6. Mkrtumian A.M., Biriukova E.V. Novye perspektivy uspeshnoi terapii postmenopauzal'nogo osteoporoza. Effektivnaia farmakoterapiia v endokrinologii 2007; 4: 20-26.
  7. Nasonov E.L. Osteoporoz: standarty diagnostiki i lecheniia. Consilium medicum 2001; 9: 416-420.
  8. Nasonova V.A. Perspektivy razvitiia revmatologii v XXI. Terapevticheskii arkhiv 2008; 5: 5-8.
  9. Rozhinskaia L.Ia., Arapova S.D., Dzeranova L.K. Issledovanie effektivnosti i bezopasnosti lecheniia bivalosom (strontsiia ranelat) postmenopauzal'nogo osteoporoza: rezul'taty Rossiiskogo mnogotsentrovogo issledovaniia. Terapevticheskii arkhiv 2008; 5: 47-52. 10. Toroptsova N.V. i dr. Strontsiia ranelat v lechenii postmenopauzal'nogo osteoporoza: rezul'taty primeneniia v klinicheskoi praktike. Nauchno-prakticheskaia revmatologiia 2008; 3: 23-28.
  10. Shvarts G.Ia. Farmakoterapiia osteoporoza. M. Meditsinskoe informatsionnoe agentstvo 2002; 368.
  11. Bonnelye E. Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 2008; 42: 129-138.
  12. Chapuy M.C., Meunier P.J. Vitamin D insuffi ciensy in adults and in eldertly. Vitamin D. San Diego: Academic Press 1997: 679-694.
  13. Chen J.T. 1 alpha-hydroxyvitamin D3 treatment decreases bone turnover and modulates calcium regulating hormones in early postmenopausal women. Osteoporosis intern 1996; 6; 1; 237.
  14. Eisman J.A. Pharmacogenetics of the vitamin D receptor and osteoporosis. Drug Met. Disp. 2001; 29: 505-512.
  15. Jureneva S.V., Smetnik V.P. Use of strontium ranelate in the treatment of postmenopausal osteoporosis. Int. Congress of Gynecol. Endocrinol. Italy 2008; 280.
  16. Marquis P. Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis. Osteoporos Int. 2008; 19: 503-510.
  17. Okamura W., Gui-Dong Zhu. Chemistry and design: structural biology of vitamin D action. Vitamin D. San Diego: Academic Press 1997: 939-972.
  18. Reginster J.Y. Effect of long-term strontium ranelate treatment on the risk of non-vertebral and vertebral fractures in postmenopausal osteoporosis: results of a 5-year, randomized, placebo controlled trial. Arthritis Rheum 2008; 58; 6: 1687-1695.
  19. Roux C. Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis. Ann .Rheum .Dis. 2007; 66; 11; 681. 21. Seeman E. Strontium Ranelate Reduces the Risk of Vertebral Fractures in Patients With Osteopenia. J. Bone Miner Res. 2008; 23: 433-438.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies